Close

CYTX Financial Facts

Other income (expense), net: -696K
Cost of product revenues: 945K
See Full Income Statement

Total assets: 34.61M
Long-term deferred rent: -324K
See Full Balance Sheet

Cytori Therapeutics (CYTX) Earnings

  |   Expand Research on CYTX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -1.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/1/19 Q418 -$0.20-$0.30 +$0.10$376K$1.89M N/A Details
11/14/18 Q318 -$0.27-$0.30 +$0.03N/A$1.89M N/A Details
8/14/18 Q218 -$0.59-$0.45 -$0.14N/A$1.86M N/A Details
5/10/18 Q118 -$0.07-$0.06 -$0.01$1.6M$2.74M = Details
3/8/18 Q417 -$0.10-$0.06 -$0.04$1.5M$2.74M = Details
11/9/17 Q317 -$0.14-$0.13 -$0.01$1.8M$2.5M = Details
8/10/17 Q217 -$0.19-$0.21 +$0.02$1.5M$2.23M = Details
5/11/17 Q117 -$0.26-$0.28 +$0.02$1.6M$2.57M = Details